Larissa Morgan

Week in Review

Week in Review

FDA issues heightened standards for antibody tests, the Department of Justice announces first arrests for COVID-19 emergency lending fraud, and more…

Week in Review

Week in Review

Congress passes additional legislation to combat COVID-19, the D.C. Circuit hears oral arguments by phone, and more…

Combatting Covert Chemistry Operations

Combatting Covert Chemistry Operations

To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.

Week in Review

Week in Review

CMS issues temporary waivers to hospitals amid the coronavirus pandemic, the Trump Administration rolls back vehicle emissions standards, and more…

An Epidemic Meets a Pandemic

An Epidemic Meets a Pandemic

Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.

The Regulatory Race Against a Public Health Crisis

The Regulatory Race Against a Public Health Crisis

The federal government responds to the coronavirus pandemic by amending its foreign quarantine rules.

Proposed Rule Seeks to Promote Value-Based Health Care

Proposed Rule Seeks to Promote Value-Based Health Care

Federal regulators seek to expand safe harbors for provider care coordination arrangements.

Relaxing Patient Privacy Laws to Tackle Substance Abuse

Relaxing Patient Privacy Laws to Tackle Substance Abuse

To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.

The Regulatory Battle Over Safe Injection Sites

The Regulatory Battle Over Safe Injection Sites

As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.